Indegene, a technology-led healthcare solutions provider today announced the appointment of industry commercialization expert, Nancy Phelan, as SVP.
Nancy is a recognized life sciences thought leader, digital pioneer and change agent with 25+ years of experience in commercial strategy and operations.
At Indegene, Nancy will lead the omnichannel commercialization business organization that partners with leading biopharma, emerging biotech and medical technology organizations as they rethink their Go-To-Market (GTM) models for Healthcare Professionals (HCPs) and Patients. Through a digital-first omnichannel engagement model, Indegene helps life sciences organizations optimize their field force deployments and augment stakeholder engagement.
Announcing Nancy’s appointment, Gaurav Kapoor, Cofounder and EVP, Indegene said, “Life sciences organizations are exploring newer ways of going to market and elevating their customer experience. Nancy’s experience leading large-scale business transformation will be especially important to translate their bold visions into reality. She has been an early adopter of technology with many branded and unbranded digital campaigns to her credit, and brings a first-hand knowledge of driving commercial model innovation at Pfizer and Bristol-Myers Squibb. We are thrilled to have Nancy on-board to enable our clients’ new go-to-market models and drive business impact.”
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.